Antibody and T-cell responses to coronavirus disease 2019 vaccination in common variable immunodeficiency and specific antibody deficiency

BACKGROUND: Clinical trials of the mRNA coronavirus disease 2019 (COVID-19) vaccines excluded individuals with primary antibody deficiencies. OBJECTIVE: To evaluate whether antibody and T-cell responses to mRNA COVID-19 vaccination in patients with common variable immunodeficiency (CVID) and specifi...

Descripción completa

Detalles Bibliográficos
Autores principales: Rosenthal, Jamie A., Papa, Michelle Premazzi, Sanz, Marta, Nicholes, Samuel, Holmberg, Carissa S., Bosque, Alberto, Keswani, Anjeni, Amdur, Richard, Lynch, Rebecca M., Soriano-Sarabia, Natalia, Ein, Daniel
Formato: Online Artículo Texto
Lenguaje:English
Publicado: American College of Allergy, Asthma & Immunology. Published by Elsevier Inc. 2023
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9891791/
https://www.ncbi.nlm.nih.gov/pubmed/36736722
http://dx.doi.org/10.1016/j.anai.2023.01.025

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9891791/
https://www.ncbi.nlm.nih.gov/pubmed/36736722
http://dx.doi.org/10.1016/j.anai.2023.01.025

Ejemplares similares